BLCM - Bellicum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-98,036-91,779-69,241-48,548
Operating Activities, Cash Flows Provided By or Used In
Depreciation6,6983,5642,3061,199
Adjustments To Net Income13,65215,54412,7678,963
Changes In Accounts Receivables-58914106-142
Changes In Liabilities-6603,591931884
Changes In Inventories----
Changes In Other Operating Activities3,267-4,6922,2681,918
Total Cash Flow From Operating Activities-74,782-72,984-50,441-35,726
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-1,617-12,134-7,220-5,421
Investments12,0278,8429,272-81,032
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities10,410-3,2532,052-86,453
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings-3112,28919,985-4
Other Cash Flows from Financing Activities-195-442-199-7
Total Cash Flows From Financing Activities68,10978,48620,928818
Effect Of Exchange Rate Changes-98-98-98-98
Change In Cash and Cash Equivalents3,6392,249-27,461-121,361